The term "incretin hormone" refers to hormones secreted from the small intestine upon glucose challenge that are responsible for potentiating the effect of insulin in systemic glucose control (25, 51) . The two known incretins glucagonlike peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) are secreted from L and K cells (2) , respectively, although they can also be found in overlapping cell populations (29) . Antibody neutralization or loss of the corresponding hormone receptors leads to hyperglycemia (33) . Exogenous administration of GLP-1 analogs or inhibitors of DPP IV, the enzyme responsible for rapid GLP-1 breakdown in the bloodstream, is utilized in the treatment of type 2 diabetes (36) . Furthermore, increased GLP-1 levels have been implicated in the rapid glycemic control that is observed after gastric bypass surgery (16) . The importance of incretin function has been further highlighted by genome-wide association studies of patients with type 2 diabetes, which have identified single nucleotide polymorphisms in the receptor for GIP (64) . While the important role of the intestine in metabolic disease is now recognized (6) , it is still unknown if alterations in intestinal gene function itself contribute to the pathogenesis of obesity or diabetes.
Several transcription factors have been implicated in the development of the enteroendocrine cells. Neurog3, as revealed by lineage tracing, is expressed in the precursor cell to all enteroendocrine cells (39) . Furthermore, loss of Neurog3 in mice results in a loss of most enteroendocrine lineages (39, 44, 52) , similar to the reports of congenital diarrhea in humans (71) . Subsets of enteroendocrine cells are specified by NeuroD (56, 57) , Insm1 (27) , FoxA1/2 (43, 75) , Pax4, and Pax6 (4, 43) . Some transcription factors act as activators and repressors of endocrine cell fate such as PTEN (63) , Nkx2.2 (15) , and Arx (4, 19) .
Interestingly, human mutations in ARX have been also been associated with cases of severe, even fatal, congenital diarrhea (41) . In the mouse pancreas, Arx is required for the specification of ␣-cell fate in the islets of Langerhans (10, 11, 31) and acts downstream of Islet1 (46) . Islet1 (Isl1) is a member of the LIM homeodomain transcription factor family (37) , promoting expression of both somatostatin and preproglucagon in endocrine cell lines (45, 72) and whose expression is lost in FoxA1/2 intestinal mutant animals with impaired enteroendocrine development (75) . Isl1 has important functions in the heart, brain, and hindlimb (23, 42, 48) with Isl-expressing cells marking multipotent cardiac progenitors (7) . Isl1 is also required for the formation of both the exocrine and endocrine compartment of the pancreas (1, 18) .
In the intestine, Isl1 expression is restricted to enteroendocrine cells (13) , although its function in the intestine has yet to be explored. Here, we find that Isl1 is expressed in a subset of enteroendocrine cells that are marked by GLP-1, GIP, somatostatin (SST), gastrin, and ghrelin. In intestinal-specific Isl1 int mouse mutants, these subpopulations are lost, leading to failure to thrive and lipid malabsorption in neonatal mice. Furthermore, without the presence of incretin hormones, Isl1 int mutant mice are not able to maintain normal glucose homeostasis during oral glucose tolerance tests (OGTT).
MATERIALS AND METHODS

Animals.
The derivation of the loxP-flanked Isl1 conditional allele (Isl1 loxP ) and the Villin-Cre mouse lines has been reported previously (24, 69) . These mice were maintained on a mixed background (CD1, 129, and C57BL/6) and were cared for and handled according to a protocol approved by the Children's Hospital of Philadelphia's Institutional Animal Care and Use Committee. Primers for genotyping alleles used in this study were 5=-GGTCTCTGGAACATCCCACAT-P7 E15.5 TGT-3= and 5=-TCAACAGTAAAATCTCTCCCTCCC-3= for Isl1 loxP and 5=-GCGGCATGGTGCAAGTTGAAT-3= and 5=-CGTTCACCG-GCATCAACGTTT-3= for Cre. Daily weights were measured at mid-day after using toe marking to identify animals. Statistical significance for growth curves was determined using repeated-measures ANOVA in Graphpad PRISM software. Unless otherwise noted, animals were analyzed at 4 -5 wk of age.
Immunohistochemistry and immunofluorescence. Tissues were fixed in 4% paraformaldehyde overnight at 4°C and embedded in paraffin or optimal cutting temperature freezing medium, and 8-m sections were collected. Slides were subjected to microwave antigen retrieval in 10 mmol/l sodium citrate buffer (pH 6.0). Endogenous peroxidase activity was blocked with 3% H 2O2 in PBS for 15 min, and sections were blocked with CAS Block reagent (Invitrogen). The sections were incubated with primary antibodies overnight at 4°C and appropriate secondary antibodies for 2 h at room temperature. Immunohistochemical detection was performed with the VECTASTAIN ABC kit (Vector Laboratories) and diaminobenzidine tetrahydrochloride as the substrate. For immunofluorescence, secondary antibodies were directly conjugated to Cy3 or Cy2 and incubated for 4 h at room temperature. The primary antibodies used were as follows: goat anti-somatostatin (1:3,000; Santa Cruz sc7819), rabbit anti-somatostatin ( (1:100; Abcam ab37994), and anti-lysozyme (1:3,000; Dako A0099). Sections were stained with hematoxylin and eosin, Oil Red O, and alkaline phosphatase according to standard protocols. Oil Red O staining was performed using frozen sections. Hormone-positive cells from different regions of the intestine were counted and normalized to the respective epithelial area of the same or adjacent sections yielding cell numbers per millimeter squared tissue area. Epithelial area was measured with Aperio Image Analysis System. At least three control and three mutant animals (4 -5 wk of age) were utilized for each hormone analysis in the intestine.
Real-time RT-PCR analysis. All tissue dissections were performed in cold 1ϫ PBS, and tail snips were taken for genotyping. Total RNA was extracted in TRIzol (Invitrogen). Oligo-dT, Superscript Plus, and other required reagents were used to synthesize cDNA. PCR reactions Glucose tolerance tests and glucose-stimulated insulin secretion. Following a 16 h fast, 3-mo-old animals (n ϭ 7 per group) received oral gavage or intraperitoneal injection of 2 mg/g body wt glucose in sterile PBS. Blood glucose was measured using an automatic glucometer (One Touch Ultra; LifeScan, Milpitas, CA) at 0, 15, 30, 60, 90, and 120 min after gavage/injection. For the glucose-stimulated insulin secretion (GSIS), serum was collected at 0, 2, 5, 15, and 30 min after gavage/injection and placed on dry ice. Insulin levels were determined in duplicate using the Crystal Chem Ultra Sensitive Mouse Insulin ELISA Kit. Statistical significance was determined using a Student's t-test for each time point, and the area under the curve was calculated in GraphPad PRISM software with the mean time zero glucose measurement as the baseline.
High-fat diet and comprehensive lab animal monitoring. At 3 mo of age, control littermate and Isl1 int mice were placed on a 45% calories from fat diet (Harlan Laboratories). The mice were weighed weekly, and stool was collected for an Oil Red O stain. After 14 -16 wk on a high-fat diet, mice underwent both nuclear magnetic resonance (NMR) body composition analysis (EchoMRI; Houston, TX) and comprehensive lab animal monitoring (CLAMS; OxyMax, Columbus, OH) to determine caloric intake, stool output, heat production, activity, and respiratory exchange ratio. The 24-h monitoring was performed at the University of Pennsylvania Mouse Phenotyping, Physiology, and Metabolism Core.
Serum and stool lipid analysis. Mice were fasted for 16 h after 10 -12 wk on a high-fat diet and then plasma or serum was collected for use with the Wako NEFA-HR (2) 
RESULTS
Islet1 is expressed in the endocrine cells of the small intestine, primarily in CGA-negative cells. We examined the expression of Isl1 in the duodenum and ileum by immunohistochemistry in adolescent mice after weaning (4 -5 wk of age). In both the proximal and distal small intestine, a strong nuclear stain was detected in scattered epithelial cells in addition to mesenchymal tissue. Isl1-positive cells were present in both the crypts and villi of the epithelium in a pattern suggestive of enteroendocrine cells (Fig. 1, A-C) and similar to its expression in the gastric epithelium (13) Fig. 2, A-I ). CGA and 5-HT (serotonin) are found in a high percentage of enteroendocrine cells (62, 68) . Although initially proposed as a pan-endocrine marker, CGA is not expressed in all enteroendocrine cells (9, 61, 63, 73) . Interestingly, Isl1 expression overlapped with Ͻ3% of CGA-positive cells (Fig. 1, D and E) and only one 5-HT ϩ /Isl1 ϩ cell was found among over 1,000 5-HT cells counted in the duodenum (Fig. 1, F-H) .
To determine which enteroendocrine cells express Isl1, we performed dual label immunofluorescence studies using antibodies to multiple gut hormones. SST has been demonstrated to define an independent population of enteroendocrine cells that do not coexpress CCK, GIP, or GLP-1 (21) . Furthermore, CGA is only expressed at very low levels in GIP and GLP-1- expressing cells of the upper small intestine (29) . To confirm previous reports that SST and CgA rarely overlap (61), we tested two different SST antibodies and three different CgA antibodies (Fig. 2, I-K (Fig. 3, A-D) . Isl1 also overlaps with the CCK population, although technical difficulties did not allow us to determine the precise percentage of coexpression (Fig. 3E) .
Hormone cell populations are altered with loss of epithelial
Isl1. The colocalization of nuclear Isl1 protein in a specific subset of enteroendocrine cells raised the possibility that this transcription factor might be required for the differentiation or maintenance of enteroendocrine cells. We crossed Villin-Cre with Isl1 loxP animals to ablate Isl1 in the intestinal epithelium. For simplicity, the experimental Isl1 loxP/loxP ;Villin-Cre mice will be referred to as Isl1 int in this article. These mice did not demonstrate any increased mortality or reduced fertility. As expected, epithelial expression of Isl1 was lost in Isl1 int mice while mesenchymal expression of Isl1 was maintained, as determined by immunohistochemistry (see Fig. 5A ). By quantitative RT-PCR (qRT-PCR), Isl1 mRNA expression was reduced in the mutant animals, although not significantly when analyzing the whole intestine, likely due to the remaining mesenchymal Isl1 mRNA expression (data not shown).
To determine if Isl1 is required for the differentiation or maintenance of enteroendocrine cells, we examined the cell populations in which Isl1 is predominantly expressed in the duodenum in 4-to 5-wk-old animals. First, we evaluated the expression of various hormones by qRT-PCR (Fig. 4) . Transcripts for somatostatin, preproglucagon, and GIP were reduced at least 20-fold in Isl1 int mice. Expression of CCK was significantly reduced as well, by about fivefold. In addition, ghrelin mRNA expression also trended down by twofold, but the difference was not statistically significant (data not shown). Expression of CGA, which is rarely coexpressed with Isl1 (see above), was not changed (data not shown). Messenger RNA levels of tryptophan hydroxylase 1 (Tph1; encodes serotonin/ 5-HT), in which cells Isl1 is also not expressed, were mildly, but significantly, elevated by 1.6-fold.
Next, we determined expression of the relevant hormones by immunohistochemistry and calculated the number of positive cells per epithelial area (Fig. 4) . Similar to the qRT-PCR results, the number of SST-, GLP-1 (protein product of the preproglucagon mRNA in intestinal L-cells)-, and GIP (K cells)-positive cells was dramatically reduced, with very few hormone-positive cells detectable in Isl int mice. The CCK population was also significantly downregulated, while the number of ghrelin-positive cells was reduced but not significantly. The number of 5-HT (serotonin) cells again was significantly upregulated by 1.7-fold, corresponding to the change in Tph1 mRNA levels. The CGA population was unchanged (data not shown).
Loss of epithelial Isl1 results in neonatal fat malabsorption and poor weight gain. To determine if growth was affected by the loss of intestinal epithelial Isl1, mice were weighed daily until weaning at postnatal day (P)21. Beginning in the second week of life, female Isl1 int mutant mice were significantly smaller than their littermate controls (Fig. 5 , E and F; males P value ϭ 0.381; females P Ͻ 0.05). Using hematoxylin and eosin staining to compare the morphology of the tissue, we found no gross difference between control and mutant animals at 4 wk of age (Fig. 5, B and C) . Also, the brush border was intact in Isl1 int animals as determined by alkaline phosphatase stain (Fig. 5D) .
Both neonatal male and female Isl1 int mutant mice had soft stools. As fat malabsorption has been noted in both Neurog3 and Arx intestinal gene deletion models (19, 52) , we tested stool and tissue for excess neutral lipid by Oil Red O staining. At P7, when neonatal pups are nursing on high-fat milk, there was an obvious increase in Oil Red O staining in the stool of the female and male Isl1 int mutant mice, suggesting a decreased ability to absorb lipid (Fig. 6A) . Furthermore, Oil Red O accumulated in epithelial cells of the ileum and in the colonic epithelium cells closest to the lumen in Isl1 int mutant mice (Fig. 6, C and D) . This phenotype disappeared when animals were switched to the standard rodent chow diet after weaning, a diet that has a very low-fat content. There was no detectable difference in the Oil Red O staining of the stool (Fig. 6B) or epithelial tissue of control and Isl-1 int mutant mice at P28, 1 wk after weaning (data not shown).
Adult Isl1 int mice process lipid normally on a high-fat diet. Since neonatal Isl1 int mice had lipid malabsorption on a highfat nursing diet, we tested if the lipid malabsorption recurred in adults fed a high-fat diet. We placed both male control and Isl1 int 3-mo-old mice on a high-fat diet (45% calories from fat) and tested stool smears for Oil Red O weekly. Even after 12 wk on a high-fat diet, no Oil Red O was present in the stool of Isl1 int or control adult mice (data not shown). Weight gain was carefully followed over this time period, but there was no significant difference in body weight overall (Fig. 7A) .
Since mice lacking CCK have an impaired metabolic profile on a high-fat diet (47), we tested both fat/lean content of the mice by NMR analysis as well as food intake, stool output, heat production, activity, and respiratory exchange ratio during a 24-h monitoring period after 14 -16 wk on the high-fat diet. The control and Isl1 int mice demonstrated no difference in fat/lean composition (Fig. 7B) , food or water intake (Fig. 7C) , total stool output (Fig. 7D) , or total lipid content of the stool (Fig. 7E) . The Isl1 int mice also did not have any impairment in activity, heat production, or respiratory exchange rate (data not shown). The intestine was stained with Isl1 and SST, which confirmed continued ablation of Isl1 and reduction in SSTexpressing cells (data not shown).
Intestinal Isl1 mutants display impaired oral glucose tolerance. With the dramatic loss of the incretin hormones GLP-1 and GIP, we hypothesized that oral glucose tolerance would be impaired in Isl1 int mice. Therefore, we tested the response of the Isl1 int mice compared with littermate controls with an OGTT in 3-mo-old animals. Isl1 int female mice were significantly more hyperglycemic 15 min after administration of the glucose bolus while Isl1 int male mice were significantly more hyperglycemic at 30 and 60 min after an oral glucose bolus (Fig. 8, A and B) . This hyperglycemia returned to normal levels as the oral glucose load was cleared. The area under the curve was significantly larger in Isl1 int males compared with control littermates (P value ϭ 0.045; Fig. 8E ), although we did not observe a difference in this measure in females. To determine if the glucose intolerance was due to a loss of the incretin effect, mice were also challenged with an intraperitoneal glucose tolerance test (IPGTT). The control and Isl1 int mice did not demonstrate any difference in glucose levels during IPGTT, as expected (Fig. 8, C-E) .
Since the loss of the incretin hormones should affect insulin levels, we performed GSIS during both OGTT and IPGTT in male mice (seven 3-to 4-mo-old male mice of each genotype were available for testing). During OGTT, significantly less insulin was secreted in the Isl1 int mice overall as demonstrated by area under the curve (Fig. 8 , G and I; P ϭ 0.007). No difference in insulin levels was detected during IPGTT (Fig. 8,  H and I ).
DISCUSSION
Our study describes a novel mouse model of congenital diarrhea and impaired glucose homeostasis. Without Isl1 in the small intestine epithelium, neonatal mice have poor growth and lipid malabsorption. Furthermore, the loss of incretin signaling from the intestine leads to glucose intolerance and reduced insulin secretion. Several subsets of enteroendocrine cells are lost. GLP-1, GIP, and somatostatin-expressing cells are nearly completely eliminated, while CCK-positive cells are significantly reduced and 5-HT (serotonin) cells are significantly upregulated. Interestingly, there is no overall change in the CGA population, which is expected since Isl1 is minimally expressed in this cell population.
Ultimately, with the loss of these enteroendocrine populations, the Isl1 int mice have impaired oral glucose tolerance. The pancreatic insulin response is more robust after oral glucose compared with intravenous glucose administration (25, 51) . Mice with gene ablation of both the GIP receptor and the GLP1 receptor have helped to elucidate the role of both of these incretin hormones in glucose homeostasis, with impaired glucose tolerance in GLP1 receptor null (GLP1R Ϫ/Ϫ ; Ref. 65 ), GIP receptor null (GIPR Ϫ/Ϫ ; Ref. 54) , and the double incretin null mouse (DIRKO; Ref. 32). In the intestine, however, loss of GIP itself does not impair glucose tolerance (58) . It is difficult to ablate only the intestinal GLP-1 protein, as it is derived from the preproglucagon transcript produced in both the intestine and pancreas where glucagon is produced from the same precursor and functions to increase glucose levels during hypoglycemia (reviewed in Ref. 40) . With the preproglucagon gene (34) or the glucagon receptor ablation (GCGR Ϫ/Ϫ ; Ref. 26) , mice are hypoglycemic in response to intraperitoneal glucose; oral glucose tolerance was not tested in these models.
Thus the Isl1 int model is particularly informative for understanding incretin signaling, since both GIP and GLP-1 populations are lost. The incretin response is quite rapid, with high levels of GLP-1 and GIP secreted within minutes of an oral glucose load (35) . This rapid response is notable in our findings that the Isl1 int mice are significantly hyperglycemic between 15-60 min after oral glucose challenge but then slowly return to normal levels. Furthermore, insulin secretion was also significantly diminished in Isl1 int mice compared with controls in response to OGTT. The Isl1 int mice did not have any impairment with IPGTT, as expected for a pure incretin defect. The glucose tolerance curves of Isl1 int mice most closely resemble heterozygous GLP1 receptor knockout mice, suggesting the small intestine is not the only source of GLP-1 (66) or that the other endocrine hormones affected in Isl1 int mice also contribute to glucose homeostasis. The signaling of the incretin hormones and other enteroendocrine hormones is quite complex; additionally, the central nervous system is also a source of GLP-1 (17) .
Glucose homeostasis has also been tested in intestinalspecific Neurog3 mutant mice (52) , demonstrating that loss of all the enteroendocrine cell population leads to poor weight gain and relative hypoglycemia after oral glucose challenge. However, since these mice have lean body mass, the hypoglycemia is difficult to interpret from the perspective of specific hormonal secretion. NEUROG3 mutations are known to play a role in congenital diarrhea in humans (71) and are linked to malabsorptive diarrhea with neonatal diabetes (60) . Like Neurog3, Isl1 is involved in early pancreatic development (1, 28) . A pancreatic-specific deletion of Isl1 in mice leads to loss of pancreatic endocrine mass, including islet ␤-cells, and subsequent hyperglycemia (18) . ISLET1 has been implicated in the pathogenesis of type 2 diabetes through genome-wide association studies (3, 22, 67, 74, 76) , which would be consistent with its role in both the pancreas and intestine.
In addition to NEUROG3 mutations, mutations in proprotein convertase 1/3 (PC1/3) have been described as a cause of malabsorptive diarrhea and obesity in humans (49) . PC1/3 processes many different hormones in the brain, pancreas, and intestine, where it is responsible for cleaving proglucagon into its multiple protein products including GLP-1 and GLP-2 (70) . A mouse model of PC1/3 deficiency results in growth failure and endocrinopathies (77) . Although it is suspected that multiple enteroendocrine hormones are altered with PC1/3 deficiency, the exact defect is unknown (38) . Thus the lack of the proglucagon products in the intestine may be involved in both the altered glucose homeostasis and the etiology of the diarrhea seen in Isl1 int mouse mutants and human patients with PC1/3 mutations.
The diarrhea present in the neonatal Isl1 int mice is related to lipid malabsorption with both excess fat present in the stool and in the tissue, particularly the ileum. Both GLP-1 and GLP-2 are involved in lipid absorption, with opposing effects (53) . Somatostatin is a general inhibitor of hormone secretion within the intestine, and its loss could cause increased motility (12) . Furthermore, CCK regulates the secretion of pancreatic enzymes and is involved with lipid absorption (47) . Thus the combined loss of these hormones likely leads to lipid malabsorption on a high-fat neonatal diet. The lipid malabsorption, however, did not recur when Isl1 int mice were placed on a high-fat diet. This pattern is reminiscent of patients with PC1/3 mutations who generally require intravenous nutrition in the first year of life but who can maintain their growth with full enteral feeds around toddler age (49) . Since adult Isl1 int mice did not have any lipid malabsorption or metabolic derangement on a high-fat diet, either Isl1 is required for different hormonal populations in neonatal mice, different hormones contribute to lipid absorption in the neonatal and adult periods, or a specific lipid is present in the milk for neonatal mice that is not present in a chow high-fat diet.
In summary, Isl1 is required for the specification of a subset of enteroendocrine cells leading to lipid malabsorption in neonatal mice and the loss of the incretin response in adults. This model is unique in its description of an intestinal-specific defect impairing glucose tolerance. Furthermore, it elucidates the role of Isl1 in enteroendocrine development (Fig. 9 ) and diarrheal disease. Mouse models such as Isl1 int are important for studying the link between nutrient absorption and metabolic disease.
